Virtual Symposium: Finding Joy in Healthcare in Africa

Virtual Symposium: Finding Joy in Healthcare in Africa
Dates: 1st and 2nd September 2021

‘Caring for myself is not self-indulgence, it is self-preservation, & that is an act of political warfare.”—Audre Lorde

As in other parts of the world, across the African continent, a variety of pathways to health and healing are available for those who fall ill or want to ensure wellbeing. The landscape of health and wellbeing is vast and caters to myriad experiences. However, dominant perceptions of healthcare in Africa portray it either in terms of failure, disrepair, chaos and disappointment, or as agentic creative refashioning under such circumstances. Little attention is paid, within scholarly research, to the joy that accompanies pursuing or achieving health and wellbeing.

The Southern and Eastern African Medical and Health Humanities network (SEAMHH), a regional network of Medical and Health Humanities Africa (MHHA) is hosting an interdisciplinary symposium: “Finding Joy in Healthcare in Africa”. The symposium is the first of many engagements, which will be led by our partners, the Malawi Medical Humanities Network (MHHN) in collaboration with The Art of Health. This inaugural event is devoted to how joy is considered in the provision, rituals, practices, behaviour, and interventions
that accompany healthcare. The symposium will focus on temporal perspectives—past, present and future—that engage how healthcare practitioners, health systems and people seeking healthcare in Africa approach issues of
joy, trust, confidence, or comfort at individual, familial, community or national levels. The aim is to challenge the now-taken-for-granted idea that health and healthcare systems are sources of trauma and a site for saviourism. Instead, we encourage a critical and/or creative reconsideration of the dynamic concepts of care, wellbeing and health-seeking behaviour.

In this symposium, we invite artists, activists, health practitioners and academics to re-imagine health and healthcare in Africa. The symposium offers mixed formats and will include workshops, academic papers, discussion forums and two keynote addresses.

Please send your expression of interest for participation to findingjoyconference@gmail.com by Wed. 4 August 2021. The event will introduce key themes to be further explored in our forthcoming ‘Finding Joy’ research, which focuses on developing practical tools that aim to make the healthcare experience more positive across various health sectors.

SEAMHH is preparing a special issue on the theme, which we plan to submit to British Medical Journal –Medical Humanities. We anticipate that the completed special edition will launch in June 2024.

Visit our website for more details on the programme & registration: https://www.medicalandhealthhumanities.africa/


Follow us on Twitter and Instagram @AndMHHA

 

INTRODUCTION TO CLINICAL RESEARCH METHODS TRAINING

INTRODUCTION TO CLINICAL RESEARCH METHODS

The Kamuzu University of Health Sciences (KuHES), will run a two-week intensive short course in Clinical Research Methods (CRM). The course will run from 13th to 24th September 2021 in Blantyre, Malawi. The course will be taught by researchers and academics working at KuHES, Malawi-Liverpool-Wellcome Trust and other affiliates. This short course is designed for postgraduates wishing to improve their research skills.  The course will focus on skills relevant to the early stages of research projects. 

  1. Course Outline

The main objective of the course is to teach practical skills and understanding in research methodology. The topics to be covered will include:

  1. Quantitative module: Days 1 to 5 (13th – 17th September)

A 5-day Module, structured into nine 2.5hr (1hr lecture/1.5hr practical) sessions. The aim of the module, is to introduce participants to quantitative research method designs. All practical data analysis practice sessions will be conducted using R software. 

The module will cover:

  • Introduction to R: core skills – data handling
  • The principles of study design
  • Cases, populations and data types/Data types and summary
  • Cross-sectional studies/ Introduction to cross-sectional data analysis
  • Cohort studies/ Introduction to analysis of cohort studies
  • Case-control studies/ Introduction to analysis of case control studies
  • Introduction to randomized controlled trials (RCTs)/ Analysis of RCTs
  • Power and sample size calculations/ Software for sample size calculations
  • Planning your analysis/ Getting started with statistical analysis plans
  • Measures of occurence and effect: confounding and effect modification
  1. Basic biomedical research methods module: Day 6 to 7 (20th – 21st September)

A 2-day module, structured into lecture and practical sessions. The aim of the module is to introduce participants to commonly encountered concepts and data analysis requirements (GraphPad Prism programme).

The module will cover:

  • Principles of molecular biology
  • Real time PCR
  • Whole genome sequencing
  • Microbiomes and human health
  • Introduction to immunology
  • Introduction to bioinformatics
  • Introduction to biomedical aspects of anti-microbial stewardship
  • Introduction to GraphPad Prism

 

  1. Professional Support: Day 08 to 10 (22nd – 24th September)

A 3-day Module, structured into 2.5hr (1.5hr lecture / 1hr practical) sessions. The aim of the module, is to equip participants with the basic skills and understanding required for quality research, including: ethics, financial management, information literacy, and to orientate participants to the standards expected of them in scientific writing, oral presentations, and documentation. The module will cover:

  • Scientific writing and presentation
  • Ethics of health research and writing an informed consent form
  • Requirements for submission of research protocol to IRBs
  • Principles of accounting, budgeting and grant management
  • Investigator site file and SOPs
  • Information literacy skills
  • Introduction to electronic data capture and ODK design practical
  1. Methods of Assessment and credits

No formal assessment.  Attendees will get a certificate of attendance and course materials.

  1. Duration:

2 weeks delivered course (excluding weekends), from 13th to 24th September 2021.

  1. Fees:
  • US$200.00 for externals and US$100.00 for internals. Internals refer to postgraduate students from KuHES and its affiliates. The fee for externals also applies to international applicants.
  • Details of method of payment will be shared with candidates following shortlisting
  • Scholarships will be offered to a few selected candidates on merit. Scholarships are only to candidates resident in Malawi.
  1. Venue:

Kamuzu University of Health Sciences (Formerly College of Medicine), Mahatma Gandhi Campus, Blantyre, Malawi (ICT Lab, Room 828, Chimutu Building)

  1. Enrolment and Eligibility:
  • We shall enroll a maximum of 30 participants. Selected candidates will be notified through emails to provide proof of payment within a specified period. Failure to do so, candidates shall forfeit their places.
  1. We shall consider all postgraduate applications received from students registered with accredited academic institutions in Malawi and internationally. Candidates in training under a clinical research group are also encouraged to apply.
  2. Accommodation and travel:

All participants are expected to cover their travel and accommodation costs.

  1. Registration:
  • To apply, please download the CRM application form from the web address (URL) below:

https://drive.google.com/file/d/1i20aoXSvYTyCOWQ11jhAxsJgpP3Lcpq_/view

  • Completed forms should be emailed to hnti@medcol.mw.
  • Candidates asking for bursary/scholarship should also submit a CV and a one page letter of motivation.
  1. Application deadline:
  • The deadline for receiving applications is 16th August, 2021.

 

  1. Feedback
  • Successful candidates should expect to receive feedback by 19th August, 2021.
  • Because of the large volume of applications we usually receive for this course, we are unable to offer individual feedback to unsuccessful candidates.
  1. Enquiries
  • Any questions regarding the course, should be addressed to hnti@medcol.mw

 

FUNDING OPPORTUNITIES

 FUNDING OPPORTUNITY

 

  1. BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

The purpose of this Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative is to encourage research that will develop and validate novel tools to facilitate the detailed analysis of complex circuits and provide insights into cellular interactions that underlie brain function. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful application. The development of new genetic and non-genetic tools for delivering genes, proteins and chemicals to cells of interest or approaches that are expected to target specific cell types and/or circuits in the nervous system with greater precision and sensitivity than currently established methods are encouraged. Tools that can be used in a number of species/model organisms rather than those restricted to a single species are highly desired. Applications that provide approaches that break through existing technical barriers to substantially improve current capabilities are highly encouraged.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-175.html

Application date line:

October 08, 2021

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

 

  1. BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

The purpose of this Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative is to encourage research that will develop and validate novel tools to facilitate the detailed analysis of complex circuits and provide insights into cellular interactions that underlie brain function. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful application. The development of new genetic and non-genetic tools for delivering genes, proteins and chemicals to cells of interest or approaches that are expected to target specific cell types and/or circuits in the nervous system with greater precision and sensitivity than currently established methods are encouraged. Tools that can be used in a number of species/model organisms rather than those restricted to a single species are highly desired. Applications that provide approaches that break through existing technical barriers to substantially improve current capabilities are highly encouraged.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-175.html

Application Date Line: October 08, 2021  

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  1. Systems Approach to Understand Mechanisms of Heterogeneous Response to Influenza (R01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support the identification of mechanisms behind heterogeneous responses in the population to influenza infection and/or vaccination through development and application of computational tools.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-017.html

Application Date Line: September 08, 2021

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

 

 

 

FUNDING OPPORTUNITIES

 FUNDING OPPORTUNITIES

 

  1. Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) encourages exploratory and developmental bi-phasic research. Applications are solicited to support the understanding of post-transcriptional regulation of intact and defective HIV RNA and to develop therapeutic strategies to alter RNA post-transcriptional modifications as a potential therapeutic platform for inhibiting HIV replication.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-012.html

Application Date Line: August 4, 2021,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

 

2. Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial not Allowed)

This Funding Opportunity Announcement (FOA) solicits R01 grant applications to innovate and develop the early stages of novel technologies that will enable greater than a one order of magnitude improvement in 1) DNA sequencing, and 2) methods for direct sequencing of the diversity of entire RNA molecules. Advances in genomics and more broadly in biomedical research have been greatly facilitated by cycles of technology innovation and disruption that have driven significant and sustained nucleic acid sequencing throughput and assembly quality increases combined with cost decreases and read quality improvements. The goal now is to dramatically advance DNA sequencing and direct RNA sequencing technologies at reasonable costs with the anticipation that significant innovation in any of these and related areas would make significant contributions to the mission of NHGRI and the field of genomics, including to many of NHGRI’s other technology development goals.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-21-006.html

Application Date Line:  March 1, 2022; February 1, 2023

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

3. Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial not Allowed)

 This Funding Opportunity Announcement (FOA) solicits R21 grant applications to innovate and develop the early stages of novel technologies that will enable greater than a one order of magnitude improvement in 1) DNA sequencing, and 2) methods for direct sequencing of the diversity of entire RNA molecules. Advances in genomics and more broadly in biomedical research have been greatly facilitated by cycles of technology innovation and disruption that have driven significant and sustained nucleic acid sequencing throughput and assembly quality increases combined with cost decreases and read quality improvements. The goal now is to dramatically advance DNA sequencing and direct RNA sequencing technologies at reasonable costs with the anticipation that significant exploratory innovation in any of these and related areas would make significant contributions to the mission of NHGRI and the field of genomics, including to many of NHGRI’s other technology development goals.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-21-007.html

Application Date Line:  March 1, 2022; February 1, 2023

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

 

 


oral sex with hotties movie sex scene teen pussy www xxvideo com More than just erotic film Anal with hot Latina babe Foxy hottie loves anal